A Novel Nomogram for Peritoneal Mesothelioma Predicts Survival

被引：0
|
作者：
Nicholas P. Schaub
Meghna Alimchandani
Martha Quezado
Phil Kalina
John S. Eberhardt
Marybeth S. Hughes
Tatiana Beresnev
Raffit Hassan
David L. Bartlett
Steven K. Libutti
James F. Pingpank
Richard E. Royal
Udai S. Kammula
Prakash Pandalai
Giao Q. Phan
Alexander Stojadinovic
Udo Rudloff
H. Richard Alexander
Itzhak Avital
机构：
[1] National Cancer Institute/NIH,GI and Hepatobiliary Malignancies Section, Surgery Branch
[2] National Cancer Institute/NIH,Laboratory of Pathology
[3] National Cancer Institute/NIH,Solid Tumor Immunotherapy Section, Laboratory of Molecular Biology
[4] DecisionQ Corporation,Division of Surgical Oncology
[5] University of Pittsburgh Medical Center,Department of Surgery
[6] Montefiore Medical Center/Albert Einstein College of Medicine,Department of Surgical Oncology
[7] The University of Texas MD Anderson Cancer Center,Department of Surgery, Division of Surgical Oncology
[8] Walter Reed National Military Medical Center,Division of Surgical Oncology, Department of Surgery and the Marlene and Stewart Greenebaum Cancer Center
[9] University of Maryland School of Medicine,undefined
[10] Bon Secours Cancer Institute,undefined
来源：
Annals of Surgical Oncology | 2013年 / 20卷
关键词：
Overall Survival; Bayesian Belief Network; Malignant Peritoneal Mesothelioma; Early Postoperative Intraperitoneal Chemotherapy; Peritoneal Carcinomatosis Index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：555 / 561
页数：6
相关论文
共 50 条
  • [21] Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
    Li, Yue C.
    Khashab, Tamara
    Terhune, Julia
    Eckert, Richard L.
    Hanna, Nader
    Burke, Allen
    Alexander, H. Richard
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (08) : 2259 - 2265
  • [22] Preoperative Thrombocytosis Predicts Shortened Survival in Patients with Malignant Peritoneal Mesothelioma Undergoing Operative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy
    Yue C. Li
    Tamara Khashab
    Julia Terhune
    Richard L. Eckert
    Nader Hanna
    Allen Burke
    H. Richard Alexander
    Annals of Surgical Oncology, 2017, 24 : 2259 - 2265
  • [23] Peritoneal mesothelioma: Long survival with intraperitoneal chemotherapy, lanreotide and mucolytics
    Montmayeur, Gaelle
    Thivat, Emilie
    Gimbergues, Pierre
    Dib, Malek
    Leheurteur, Marianne
    Cure, Herve
    Chollet, Philippe
    Durando, Xavier
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (10): : 874 - 875
  • [24] 9-YEAR SURVIVAL IN A CASE OF UNTREATED PERITONEAL MESOTHELIOMA
    NORMAN, PE
    WHITAKER, D
    MEDICAL JOURNAL OF AUSTRALIA, 1989, 150 (01) : 43 - 44
  • [25] Chemotherapy maintenance: An option for prolonged survival in malignant peritoneal mesothelioma?
    Hofer, Silvia
    Sasse, Bernd
    Scheffel, Hans
    ACTA ONCOLOGICA, 2010, 49 (01) : 125 - 127
  • [26] MALIGNANT PERITONEAL MESOTHELIOMA IN CHILDHOOD WITH LONG-TERM SURVIVAL
    GEARY, WA
    MILLS, SE
    FRIERSON, HF
    POPE, TL
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 95 (04) : 493 - 498
  • [27] Cyclooxygenase-2 predicts survival in malignant pleural mesothelioma
    O'Kane, SL
    Campbell, A
    Lind, MJ
    Cawkwell, L
    BRITISH JOURNAL OF CANCER, 2004, 91 : S28 - S28
  • [28] Positron emission tomography predicts survival in malignant pleural mesothelioma
    Flores, Raja M.
    Akhurst, Timothy
    Gonen, Mithat
    Zakowski, Maureen
    Dycoco, Joseph
    Larson, Steven M.
    Rusch, Valerie W.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2006, 132 (04): : 763 - 768
  • [29] A nomogram predicts cardiovascular events in patients with peritoneal dialysis-associated peritonitis
    Huang, Dan-Dan
    Li, Yuan-Yuan
    Qi, Xiang-Ming
    Wu, Yong-Gui
    RENAL FAILURE, 2022, 44 (01) : 1558 - 1567
  • [30] PERITONEAL MESOTHELIOMA
    KANNERST.M
    CHURG, J
    FEDERATION PROCEEDINGS, 1974, 33 (03) : 601 - 601
12345